Denali Therapeutics Ownership | Who Owns Denali Therapeutics?
Denali Therapeutics Ownership Summary
Denali Therapeutics is owned by 19.96% institutional investors, 9.28% insiders, and 70.75% retail investors. Blackrock is the largest institutional shareholder, holding 8.82% of DNLI shares. Scottish Mortgage Ord is the top mutual fund, with 4.51% of its assets in Denali Therapeutics shares.
DNLI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Denali Therapeutics | 19.96% | 9.28% | 70.75% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 13.17M | 8.82% | $305.91M |
| Vanguard group | 13.06M | 7.57% | $215.59M |
| Blackrock funding, inc. /de | 12.72M | 7.37% | $209.93M |
| Baillie gifford | 12.31M | 7.14% | $203.25M |
| Fmr | 6.34M | 3.70% | $92.06M |
| T. rowe price investment management | 5.64M | 3.29% | $81.87M |
| State street | 5.46M | 3.19% | $79.34M |
| Temasek (private) | 5.36M | 3.12% | $77.77M |
| Norges bank | 5.12M | 2.97% | $84.52M |
| Ubs asset management americas | 4.98M | 2.89% | $82.28M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Crestline management, lp | 3.41M | 85.26% | $49.52M |
| Foresite capital management vi | 1.00M | 5.61% | $14.52M |
| Stempoint capital lp | 1.73M | 5.05% | $25.19M |
| Boxer capital management | 250.00K | 1.16% | $3.63M |
| Palo alto investors lp | 408.01K | 1.10% | $5.92M |
| Casdin capital | 890.00K | 1.08% | $12.92M |
| Yiheng capital management | 469.98K | 1.01% | $6.82M |
| Monashee investment management | 91.62K | 0.85% | $1.51M |
| Lynx1 capital management lp | 261.69K | 0.77% | $3.80M |
| Dafna capital management | 168.50K | 0.60% | $2.45M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 5.12M | 0.01% | 5.12M |
| Holocene advisors, lp | 3.14M | 0.10% | 2.73M |
| T. rowe price investment management | 5.64M | 0.05% | 2.39M |
| Goldman sachs group | 3.84M | 0.01% | 1.67M |
| Vanguard group | 13.06M | 0.00% | 1.06M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 59.23K | 0.00% | -5.61M |
| Price t rowe associates inc /md/ | 4.57M | 0.01% | -2.01M |
| Flagship pioneering | - | - | -1.36M |
| Fmr | 6.34M | 0.00% | -1.20M |
| Gilder gagnon howe | - | - | -1.17M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 5.12M | 0.01% | 5.12M | $84.52M |
| Foresite capital management vi | 1.00M | 5.61% | 1.00M | $14.52M |
| Axa investment managers | 294.73K | 0.01% | 294.73K | $4.28M |
| Lynx1 capital management lp | 261.69K | 0.77% | 261.69K | $3.80M |
| Schonfeld strategic advisors | 226.20K | 0.02% | 226.20K | $3.28M |
Sold Out
| Holder | Change |
|---|---|
| Truvestments capital | -1.00 |
| Toronto dominion bank | -2.00 |
| Dinuzzo private wealth | -2.00 |
| Global financial private client | -5.00 |
| Wealthtrak capital management | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | -71.60% | 34,419,053 | -74.60% | 19 | 0.32% | 37 | -70.63% | 15 | -76.92% |
| Sep 30, 2025 | 84 | -62.83% | 32,008,693 | -75.36% | 18 | 0.33% | 39 | -67.77% | 28 | -56.25% |
| Jun 30, 2025 | 230 | 4.07% | 137,233,427 | 3.48% | 80 | 1.33% | 122 | 14.02% | 66 | -17.50% |
| Mar 31, 2025 | 220 | -3.51% | 132,840,276 | 3.83% | 77 | 1.36% | 108 | -14.96% | 80 | 35.59% |
| Dec 31, 2024 | 227 | 2.71% | 127,936,943 | 1.24% | 75 | 1.36% | 125 | 8.70% | 60 | 3.45% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Scottish Mortgage Ord | 7.04M | 4.51% | 515.41K |
| Vanguard Health Care Inv | 4.40M | 3.03% | -5.17M |
| Vanguard Total Stock Mkt Idx Inv | 4.20M | 2.69% | 15.98K |
| Vanguard US Total Market Shares ETF | 3.33M | 2.29% | -161.11K |
| State Street® SPDR® S&P® Biotech ETF | 3.30M | 2.12% | -17.68K |
| iShares Russell 2000 ETF | 3.19M | 2.04% | 1.06M |
| Vanguard US Growth Investor | 3.04M | 1.95% | 219.47K |
| Baillie Gifford US Equity Growth | 3.04M | 1.95% | 219.47K |
| Vanguard Small Cap Index | 3.00M | 1.92% | -1.42K |
| T. Rowe Price Health Sciences | 2.22M | 1.52% | -278.46K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 06, 2026 | Watts Ryan J. | President and CEO | Sell | $580.77K |
| Jan 06, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | $284.10K |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $1.91K |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | - | Buy | $20.95K |
| Aug 12, 2025 | Schuth Alexander O. | COFO and Secretary | Sell | $39.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 2 |
| 2025 Q4 | 2 | - |
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 8 |
DNLI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools